Filing Details
- Accession Number:
- 0001850902-23-000016
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-05-16 19:07:51
- Reporting Period:
- 2023-05-12
- Accepted Time:
- 2023-05-16 19:07:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1850902 | Alpha Teknova Inc. | TKNO | In Vitro & In Vivo Diagnostic Substances (2835) | 943368109 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1861134 | Stephen Gunstream | C/O Alpha Teknova, Inc. 2451 Bert Drive Hollister CA 95023 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-05-12 | 4,665 | $1.67 | 108,798 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Alpha Teknova, Inc. 2021 Employee Stock Purchase Plan (the ESPP), for the ESPP purchase period commencing on November 15, 2022, and ending on May 14, 2023 (the Prior Purchase Period). This transaction is also exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at the lesser of (i) 85% of fair market value on the first trading day of the Prior Purchase Period, and (ii) 85% of fair market value on the last day of the Prior Purchase Period, in each case rounded up to the nearest whole cent per share.
Billionaire Hedge Funds
